Suspension of trading
Sector Adaptimmune Therapeutics plc Börse Stuttgart
Stocks
473A
US00653A1079
Pharmaceuticals
|
Market Closed -
Börse Stuttgart
10:04:00 21/05/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0100 EUR | -.--% |
|
-41.18% | -9.09% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.58% | +0.43% | -3.13% | +28.68% | +1.68% | +31.09% | -4.81% | +20.40% | +92.07% | 78.35B | |
| -2.55% | +6.99% | +144.66% | +140.84% | +422.35% | +505.27% | +47.92% | -64.18% | - | 61.52B | |
| -1.11% | +5.08% | +11.26% | +62.46% | +1.70% | -11.47% | -33.91% | -43.24% | +70.64% | 59.78B | |
| +0.14% | -1.20% | -8.69% | -2.24% | -17.52% | -11.64% | +24.21% | -2.55% | - | 46.53B | |
| -0.24% | +1.22% | -4.23% | -16.49% | -12.78% | +2.26% | +151.03% | +125.46% | +183.21% | 45.5B | |
| -1.62% | -0.76% | +1.39% | +9.62% | +22.45% | +49.85% | -14.92% | -28.21% | -29.23% | 31.84B | |
| -1.81% | +3.16% | +1.49% | +27.58% | +26.87% | +45.71% | +110.57% | +64.90% | +52.54% | 25.4B | |
| +0.47% | +3.26% | -0.05% | +26.85% | +26.69% | -0.77% | +142.41% | +45.26% | - | 21.43B | |
| +0.27% | +1.96% | -3.79% | +1.54% | +34.31% | +62.19% | +102.81% | +86.17% | +339.10% | 15.77B | |
| -1.04% | -8.05% | -19.73% | +0.51% | -12.92% | +24.90% | +133.39% | +27.80% | - | 13.02B | |
| -0.20% | -5.41% | -14.93% | -10.81% | -26.69% | -30.40% | +368.11% | +394.33% | +5,509.36% | 12.71B | |
| -1.75% | -2.65% | -4.55% | +16.91% | +7.59% | +15.96% | -27.83% | -17.77% | -33.99% | 12.38B | |
| -3.03% | -5.88% | -3.67% | -17.05% | +13.76% | +75.15% | +178.64% | +599.13% | +2,726.94% | 10.88B | |
| -0.61% | -2.98% | +1.16% | -3.27% | +36.56% | +109.62% | +184.09% | +468.80% | - | 9.97B | |
| +7.35% | +31.26% | +43.83% | +90.71% | +426.45% | +497.46% | +713.79% | +37.17% | - | 10.47B | |
| -1.71% | -2.85% | -2.19% | +5.93% | -10.82% | -19.85% | -26.83% | -56.27% | -50.13% | 6.52B | |
| -2.63% | +1.27% | -2.83% | +40.16% | +87.25% | +115.03% | +345.44% | +533.63% | - | 6.03B | |
| -0.33% | +3.87% | -5.06% | +21.53% | +1.23% | -5.23% | +56.54% | -12.27% | - | 6.12B | |
| +0.37% | +6.33% | -16.26% | +0.82% | -1.47% | +9.20% | +171.24% | +194.95% | - | 5.41B | |
| Average | -0.56% | +1.49% | +6.04% | +22.33% | +54.04% | +77.07% | +137.99% | +124.92% | +886.05% | 25.24B | |
| Weighted average by Cap. | -0.80% | +2.01% | +17.78% | +34.66% | +67.45% | +91.62% | +75.17% | +50.66% | +416.06% |
- Stock Market
- Stocks
- ADAPY Stock
- 473A Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
